Sun Pharmaceutical Industries shares dropped 3.4 percent as the US FDA labelled its Dadra facility as 'official action indicated' (OAI), indicating recommended regulatory or administrative actions.
Sun Pharma Slumps 3% Sun Pharma said that the US FDA conducted an inspection at the company's Dadra facility from December 4, 2023 to December 15, 2023. The US FDA has subsequently determined the ...
Motilal Oswal is bullish on Sun Pharma has recommended buy rating on the stock with a target price of Rs 1,870 in its research report dated April 23, 2024. Dadra's specialization lies in the ...
The Food and Drug Administration continues using import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates ...
On 18 April, Mumbai-headquartered Marksans Pharma, a drugmaker that supplies generic drugs in over 50 countries around the ...
Stock Market Today- Sun Pharmaceutical Industries share price has decline 4-5% in last two trading sessions on regulatory concerns. The US drug regulator (USFDA) post conducting an inspection at ...
The Food and Drug Administration published an expanded import alert Wednesday to stop all plastic syringes made by a Chinese manufacturer from entering the U.S. On March 28, the FDA issued an ...
WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government ...
Sun Grid, unveiled seven weeks ago, has been one of the most visible software-as-a-service initiatives from new Sun CEO Jonathan Schwartz. In fact, Schwartz touts Sun Grid as the only public ...
(KFVS) - There is a chance for scattered storms in some places this morning and into the afternoon, but we are tracking a stronger possibility for severe weather Sunday night. After some ...